The William Harvey Clinical Research Centre, from where our patient-led organisation has grown, is a central part of the Barts Health research effort on COVID-19
TrialsConnect has produced brief Study Summary sheets on a number of research studies. This is part of a programme to help clinical trials patients tell their ‘Trial Story’ to family and lay audiences.
Study Summaries for selected studies on COVID-19 can be downloaded here:
His death will not be in vain…
Read the story of the first blood sample collected at Barts Health for the GenOMICC study.
Daily Telegraph, 21 May 2020
Followed up in The Guardian, 23/5/20 HERE
These new videos describe COVID-19 research to patients and relatives. They were produced by patient John Greenwood's company, Greenacre, for Barts Health NHS Trust and are available in several languages.The project was organised by Dr Manish Saxena of the William Harvey Clinical Research Centre working with Neeta Patel, Barts Health NHS Trust.
Researchers within Barts Health Trust have launched a major effort to coördinate contributions to studies on the novel coronavirus and COVID-19 in hospitals in the trust including the Nightingale field hospital at the Excel conference centre. There is a link to a Telegraph news items describing this activity below.
“…Over the last two weeks, a new generation of code breakers has been assembling not at Bletchley Park but at Charterhouse Square, a secluded tree-lined pentagonal enclave in central London. This is the campus for Barts and the London School of Medicine and Dentistry, part of Queen Mary University of London, and here the task being undertaken is just as critical as Turing’s was nearly 80 years ago; part of a national effort to help save the country from an assault that, once again, is threatening our very way of life…”
Training for the volunteer staff helping with this research is taking place at the William Harvey Clinical Research Centre, Charterhouse Square, where TrialsConnect is based.
Patients have been consulted on rapidly produced information and consent materials as well as having a representative on the coördinating group.